4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-17-008731
10% owner sold 1,650,000 shares at an average $17.39 ($28,700,395)
From the SEC's structured data for this filing
Trades in this filing
THIRD ROCK VENTURES LP · 10% owner
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-03-23 | Sale : show line 1 in the form | −1,000,000 | $17.00 | $17,000,200 | 5,820,348 | D |
| 2017-03-27 | Sale : show line 2 in the form | −650,000 | $18.00 | $11,700,195 | 5,170,348 | D |
| Open-market sales · 1,650,000 sh · avg $17.39 · $28,700,395 | ||||||
Loading xslF345X03/doc4.xml…